DETECTION OF EXTENDED-SPECTRUM -LACTAMASE ENZYMES (ESBLs) PRODUCED BY ESCHERICHIA COLI URINARY PATHOGENS AT ASSIUT UNIVERSITY HOSPITAL | ||
| Bulletin of Pharmaceutical Sciences Assiut University | ||
| Article 1, Volume 34, Issue 2, 2011, Pages 93-103 PDF (801.6 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bfsa.2011.63247 | ||
| Authors | ||
| Amany G. Thabit1; Tharwat R. El-Khamissy2; Maggie A. Ibrahim1; Adel E. Attia2 | ||
| 1Department of Microbiology and Immunology, Faculty of Medicine, Assiut University | ||
| 2Department of Microbiology, Faculty of Pharmacy, Al-Azhar University, Assiut | ||
| Abstract | ||
| This study was conducted to evaluate the rate of urinary tract infection at Assiut University Hospitals, and to determine the prevalence of extended-spectrum β-lactamase enzymes producing community- and hospital-acquired E. coli uropathogens at Urology Department in Assiut University Hospitals. Also, to perform the antimicrobial sensitivity testing for E. coli isolates to extended-spectrum cephalosporins according to CLSI. Phenotypic confirmatory tests (combined disc method, double disc diffusion method and ESBL-E-Test) were performed to test E. coli isolates for ESBL production and it was concluded that 30 (39.47%) of community isolates and 42 (70%) of nosocomial isolates were ESBLs producers. | ||
|
Statistics Article View: 313 PDF Download: 360 |
||
